Effectiveness of Reminiscence Therapy Versus Cognitive Stimulation in Older Adults With Cognitive Decline

NCT05187572 | Completed

• 1 other identifier: TRvsCS
• Study Type: interventional
• Target: 106
• Locations: 1 country
• Sites: 1

Brief Summary

Although data suggest that non-pharmacologic therapies such as Reminiscence Therapy (RT) and Cognitive Stimulation (CS) can potentially maintain or reverse this trend, cognitive impairment can be a precursor to neurodegenerative processes. This study aimed to assess how an RT and a CS program affected cognition, depressive symptomatology, and quality of life (QoL) in older persons with cognitive decline who attended community support institutions in central Portugal. For seven weeks, a quasi-experimental study with two arms (RT and CS program) was conducted. The intervention was completed by 76 of the 109 older persons who were first screened (50 in the RT program, 26 in the CS program). In both groups, a pre- and post-intervention analysis revealed statistically significant differences in cognition, particularly in older adults' delayed recall ability.

Conditions

Cognitive Decline

Outcome Measures

Primary Outcomes (6)

• Change in cognition (person with cognitive decline)

  Measured using the Montreal Cognitive Assessment (MoCA). Scale scores vary between 0 and 30 points; higher scores correspond to a higher cognition level.

  Pre-intervention (baseline)

• Change in depressive dymptomatology (person with cognitive decline)

  Measured using the 10-items Geriatric Depression Scale (GDS-10). Scale scores vary between 0 and 10 points; scores equal or above 2 points correspond to a screening diagnosis of depression.

  Pre-intervention (baseline)

• Change in quality of life (person with cognitive decline)

  Measured using the World Health Organization Quality of Life - module for older adults (WHOQOL-OLD-8). Scale scores vary between 8 and 40 points; higher scores correspond to a higher level of quality of life.

  Pre-intervention (baseline)

• Change in cognition (person with cognitive decline)

  Measured using the Montreal Cognitive Assessment (MoCA). Scale scores vary between 0 and 30 points; higher scores correspond to a higher cognition level.

  8 weeks post baseline

• Change in depressive dymptomatology (person with cognitive decline)

  Measured using the 10-items Geriatric Depression Scale (GDS-10). Scale scores vary between 0 and 10 points; scores equal or above 2 points correspond to a screening diagnosis of depression.

  8 weeks post baseline

• Change in quality of life (person with cognitive decline)

  Measured using the World Health Organization Quality of Life - module for older adults (WHOQOL-OLD-8). Scale scores vary between 8 and 40 points; higher scores correspond to a higher level of quality of life.

  Pre-intervention (baseline), 8 weeks post baseline

Study Arms (2)

Reminiscence Therapy (RT)

EXPERIMENTAL

The RT program is composed of activities that follow older adults' lifespan (e.g., school, professional life, travelling, holidays and celebrations, historical dates/moments). Such activities allow older adults to revive and share life-changing/significant moments and integrate them into their autobiographical narrative. The program was developed and validated by Gil and colleagues for Portuguese older adults with cognitive decline.

Behavioral: Group intervention

Cognitive Stimulation (CST)

EXPERIMENTAL

The CST intervention was based on the "Making a Difference" program, specifically developed for older adults with cognitive decline and previously adapted and validated to the European Portuguese language and culture. This program offers a sequence of activities that covers different cognitive domains and promotes older adults' socialization and self-esteem.

Behavioral: Group intervention

Interventions

Group intervention BEHAVIORAL

This intervention was developed during 14 sessions, held twice a week, with a duration of 45 to 60 minutes each. The sessions were developed as group-based interventions, facilitated by a leader and a co-leader from each community institution.

Cognitive Stimulation (CST); Reminiscence Therapy (RT)

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Ability to give informed consent before study commencement;
• Ability to participate in group activities for a period between 45 to 60 minutes;
• No pronounced impairment of their visual and auditory abilities;
• Mild to moderate cognitive decline, assessed as a score equal to or below 20 points in the Six-Item Cognitive Impairment Test (6-CIT).

You may not qualify if:

• Unstable clinical condition;
• Prescribed with cholinesterase inhibitors and/or antipsychotics during the study period.

Sponsors & Collaborators

• Paulo Costa: lead
• Junta de Freguesia de Santo António dos Olivais: collaborator
• Centro Sociocultural Polivalente de São Martinho: collaborator
• Centro Social e Paroquial de Carapinheira do Campo: collaborator
• Obra Social de Torre de Vilela: collaborator
• Centro Social Paroquial de Pedrulha: collaborator
• Associação Nacional de Apoio ao Idoso: collaborator
• Santa Casa de Misericórdia de Cantanhede: collaborator
• Doce Viver - Residencial Sénior, Bruscos: collaborator

Study Sites (1)

The Health Sciences Research Unit: Nursing

Coimbra, 3004-011, Portugal

Location

Related Links

• Project website

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition Disorders; Neurocognitive Disorders; Mental Disorders

Study Officials

• Rosa Silva, PhD

  Health Sciences Research Unit: Nursing, Nursing School of Coimbra

  STUDY CHAIR

• João Apóstolo, PhD

  Health Sciences Research Unit: Nursing, Nursing School of Coimbra

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Masking Details: Treatment allocation will be done per institution, after a centralized randomization process. Care providers and outcome assessors will be blinded to the allocation process.
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Researcher

Study Record Dates

• First Submitted: December 21, 2021
• First Posted: January 12, 2022
• Study Start: April 20, 2017
• Primary Completion: June 6, 2017
• Study Completion: June 6, 2017
• Last Updated: January 12, 2022

Record last verified: 2022-01

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, ICF, CSR
• Time Frame: The data presented in this study are available on request. The data are not publicly available due to ethical considerations, regarding personal information and respecting what was written in the signed informed consent.
• Access Criteria: The data presented in this study are available on request. The data are not publicly available due to ethical considerations, regarding personal information and respecting what was written in the signed informed consent.

Locations

PT (1)